Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Silo Pharma Inc

SILO ✗ NOT COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Biotechnology & Medical Research ·

USA Micro Cap Analyst: N/A

Last Close

$3.20

▼ -0.62%

Market Cap $5.08M · Vol 2.93K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$5.08M

Micro Cap

Div Yield

N/A

EPS Growth

N/A

YoY

RSI (14)

27.61

Momentum

Beta

0.49

vs Market

52W High

$15.15

78.88% below

52W Low

$2.76

15.94% above

Volume

2.93K

Avg 39.07K

P/B

0.72

Price-to-book

ROE

N/A

Return on equity

Free Float

83.59%

Public shares

Shariah Compliance8 STANDARDS

✗ Silo Pharma Inc (SILO) stock is currently not Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See which standards it fails, the exact ratios behind the verdict, and halal alternatives. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does SILO pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-14.32%

-37.62%

-45.85%

-26.69%

YTD

-37.25%

-69.18%

-88.89%

N/A

Financials & Valuation

TTM · Annual

Total Revenue	$72.10K
Net Income	$-4,227,700.00
Revenue Growth (YoY)	+0.00%
Gross Margin	38.57%
Operating Margin	-5,936.95%
Net Profit Margin	-5,863.50%
ROE	N/A
ROA · ROIC	-56.31% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	39.53
P/B	0.72
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	1.59M

Technical Indicators

50-Day SMA	$5.28
200-Day SMA	$5.80
RSI (14)	27.61
Beta	0.49
52-Week High	$15.15
52-Week Low	$2.76

Volume Today	2.93K
Avg Daily Volume (30D)	39.07K
Relative Volume	0.07x
Volatility (10D)	137.96
Volatility (30D)	139.98
Free Float	83.59%

Analyst Consensus

N/A

Current Price $3.20

Mean Target N/A

52W Low$2.76 52W High$15.15

Current

Target

$2.76 $15.15

Current Analyst target

· 0 analysts

Identifiers

ExchangeNasdaq

FIGIBBG002D1DZR7

ISINUS82711P3001

CountryUnited States of America

Sub-IndustryBiotechnology & Medical Research (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

LONN.S Lonza Group AG -1.78% RVMD Revolution Medicines Inc +0.85% ONC BeOne Medicines AG -2.40% 068270.KS Celltrion Inc -0.50% ABVX Abivax SA -2.05%

Company Profile

Silo Pharma, Inc. is a diversified developmental-stage biopharmaceutical and cryptocurrency treasury company. The Company’s therapeutic focus is on addressing underserved conditions, including stress-induced psychiatric disorders, chronic pain, and central nervous system (CNS) diseases. The Company’s portfolio includes programs, such as for PTSD, SP-26 for fibromyalgia and chronic pain, and preclinical assets targeting Alzheimer’s disease and multiple sclerosis. Its lead product candidate, SPC-15, is designed as a novel serotonin 4 (5-HT4) receptor agonist that utilizes biomarkers for treatment of stress-induced psychiatric disorders such as PTSD and anxiety disorders. SPC-14 targets glutamate receptor NDMAR and serotonin 5-HT4 to address cognitive and neuropsychiatric symptoms in Alzheimer’s disease. SPU-16 is a candidate targeting central nervous system (CNS) disorders, with an initial indication for multiple sclerosis.